348 related articles for article (PubMed ID: 31069878)
1. Macrophage migration inhibitory factor-CD74 interaction regulates the expression of programmed cell death ligand 1 in melanoma cells.
Imaoka M; Tanese K; Masugi Y; Hayashi M; Sakamoto M
Cancer Sci; 2019 Jul; 110(7):2273-2283. PubMed ID: 31069878
[TBL] [Abstract][Full Text] [Related]
2. Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-γ.
Tanese K; Hashimoto Y; Berkova Z; Wang Y; Samaniego F; Lee JE; Ekmekcioglu S; Grimm EA
J Invest Dermatol; 2015 Nov; 135(11):2775-2784. PubMed ID: 26039541
[TBL] [Abstract][Full Text] [Related]
3. Expression of MIF and CD74 in leukemic cell lines: correlation to DR expression destiny.
Georgouli M; Papadimitriou L; Glymenaki M; Patsaki V; Athanassakis I
Biol Chem; 2016 Jun; 397(6):519-28. PubMed ID: 26866879
[TBL] [Abstract][Full Text] [Related]
4. CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.
Zheng YX; Yang M; Rong TT; Yuan XL; Ma YH; Wang ZH; Shen LS; Cui L
World J Gastroenterol; 2012 May; 18(18):2253-61. PubMed ID: 22611320
[TBL] [Abstract][Full Text] [Related]
5. 4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas.
Varinelli L; Caccia D; Volpi CC; Caccia C; De Bortoli M; Taverna E; Gualeni AV; Leoni V; Gloghini A; Manenti G; Bongarzone I
Endocr Relat Cancer; 2015 Oct; 22(5):759-75. PubMed ID: 26206776
[TBL] [Abstract][Full Text] [Related]
6. Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.
Richard V; Kindt N; Decaestecker C; Gabius HJ; Laurent G; Noël JC; Saussez S
Oncol Rep; 2014 Aug; 32(2):523-9. PubMed ID: 24939415
[TBL] [Abstract][Full Text] [Related]
7. LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
Klasen C; Ziehm T; Huber M; Asare Y; Kapurniotu A; Shachar I; Bernhagen J; El Bounkari O
Cell Signal; 2018 Jun; 46():32-42. PubMed ID: 29476963
[TBL] [Abstract][Full Text] [Related]
8. Regulation of programmed death ligand 1 expression by interferon-γ and tumour necrosis factor-α in canine tumour cell lines.
Owaki R; Deguchi T; Konnai S; Maekawa N; Okagawa T; Hosoya K; Kim S; Sunaga T; Okumura M
Vet Comp Oncol; 2023 Jun; 21(2):279-290. PubMed ID: 36802270
[TBL] [Abstract][Full Text] [Related]
9. Role of MIF/CD74 signaling pathway in the development of pleural mesothelioma.
D'Amato-Brito C; Cipriano D; Colin DJ; Germain S; Seimbille Y; Robert JH; Triponez F; Serre-Beinier V
Oncotarget; 2016 Mar; 7(10):11512-25. PubMed ID: 26883190
[TBL] [Abstract][Full Text] [Related]
10. Triptolide suppresses oral cancer cell PD-L1 expression in the interferon-γ-modulated microenvironment in vitro, in vivo, and in clinical patients.
Kuo CS; Yang CY; Lin CK; Lin GJ; Sytwu HK; Chen YW
Biomed Pharmacother; 2021 Jan; 133():111057. PubMed ID: 33378962
[TBL] [Abstract][Full Text] [Related]
11. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.
Homma S; Hayashi K; Yoshida K; Sagawa Y; Kamata Y; Ito M
Int Immunopharmacol; 2018 Jan; 54():39-45. PubMed ID: 29100036
[TBL] [Abstract][Full Text] [Related]
12. Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma.
Fukuda Y; Bustos MA; Cho SN; Roszik J; Ryu S; Lopez VM; Burks JK; Lee JE; Grimm EA; Hoon DSB; Ekmekcioglu S
Cell Death Dis; 2022 Feb; 13(2):117. PubMed ID: 35121729
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 expression is increased in a subset of basal type breast cancer cells.
Soliman H; Khalil F; Antonia S
PLoS One; 2014; 9(2):e88557. PubMed ID: 24551119
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of macrophage migration inhibitory factor in the pathogenesis of UV-induced cutaneous nonmelanoma skin cancer.
Heise R; Vetter-Kauczok CS; Skazik C; Czaja K; Marquardt Y; Lue H; Merk HF; Bernhagen J; Baron JM
Photochem Photobiol; 2012; 88(5):1157-64. PubMed ID: 22324658
[TBL] [Abstract][Full Text] [Related]
15. Serum Levels of Migration Inhibitory Factor (MIF) and
Martinez-Guzman MA; Alvarado-Navarro A; Delgado-Rizo V; Garcia-Orozco A; Mayorga-Rodríguez JA; Pereira-Suarez AL; Fafutis-Morris M
Front Immunol; 2018; 9():246. PubMed ID: 29487601
[TBL] [Abstract][Full Text] [Related]
16. 5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers.
Van Der Kraak L; Goel G; Ramanan K; Kaltenmeier C; Zhang L; Normolle DP; Freeman GJ; Tang D; Nason KS; Davison JM; Luketich JD; Dhupar R; Lotze MT
J Immunother Cancer; 2016; 4():65. PubMed ID: 27777774
[TBL] [Abstract][Full Text] [Related]
17. PD-L1: PD-1 interaction contributes to the functional suppression of T-cell responses to human uveal melanoma cells in vitro.
Yang W; Chen PW; Li H; Alizadeh H; Niederkorn JY
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2518-25. PubMed ID: 18296654
[TBL] [Abstract][Full Text] [Related]
18. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
19. Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects.
Xu L; Zhang Y; Tian K; Chen X; Zhang R; Mu X; Wu Y; Wang D; Wang S; Liu F; Wang T; Zhang J; Liu S; Zhang Y; Tu C; Liu H
J Exp Clin Cancer Res; 2018 Oct; 37(1):261. PubMed ID: 30373602
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor promotes the migration of dendritic cells through CD74 and the activation of the Src/PI3K/myosin II pathway.
Ives A; Le Roy D; Théroude C; Bernhagen J; Roger T; Calandra T
FASEB J; 2021 May; 35(5):e21418. PubMed ID: 33774873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]